Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients
Conditions: Hodgkin Lymphoma; Lymphoid Leukemia; Multiple Myeloma; Myeloid Leukemia; Monocytic Leukemia; Non Hodgkin Lymphoma; Myelodysplasia Intervention: Drug: Intravenous (IV) and oral Vitamin C Sponsor: Virginia Commonwealth University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants | Vitamin C | Vitamins